For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug
US $3.04US $3.04
Sep 13, 12:25Sep 13, 12:25
Picture 1 of 1
Gallery
Picture 1 of 1
Have one to sell?
For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug
US $3.04
ApproximatelyS$ 3.93
Condition:
Very Good
A book that has been read but is in excellent condition. No obvious damage to the cover, with the dust jacket included for hard covers. No missing or damaged pages, no creases or tears, and no underlining/highlighting of text or writing in the margins. May be very minimal identifying marks on the inside cover. Very minimal wear and tear.
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Shipping:
US $4.49 (approx S$ 5.80) Economy Shipping.
Located in: Tucker, Georgia, United States
Delivery:
Estimated between Thu, 2 Oct and Tue, 7 Oct to 94104
Returns:
30 days return. Buyer pays for return shipping. If you use an eBay shipping label, it will be deducted from your refund amount.
Coverage:
Read item description or contact seller for details. See all detailsSee all details on coverage
(Not eligible for eBay purchase protection programmes)
Seller assumes all responsibility for this listing.
eBay item number:146753383764
Item specifics
- Condition
- Book Title
- For Blood and Money: Billionaires, Biotech, and the Quest for a
- ISBN
- 9780393540956
About this product
Product Identifiers
Publisher
Norton & Company, Incorporated, w. w.
ISBN-10
0393540952
ISBN-13
9780393540956
eBay Product ID (ePID)
16057239265
Product Key Features
Number of Pages
288 Pages
Language
English
Publication Name
For Blood and Money : Billionaires, Biotech, and the Quest for a Blockbuster Drug
Subject
Industries / Pharmaceutical & Biotechnology, Internal Medicine, Research & Development
Publication Year
2023
Type
Textbook
Subject Area
Business & Economics, Medical
Format
Hardcover
Dimensions
Item Height
1 in
Item Weight
16.6 Oz
Item Length
9.3 in
Item Width
6.2 in
Additional Product Features
Intended Audience
Trade
LCCN
2022-057318
Reviews
[A] fascinating story of... the financial arrangements, medical controversies, regulatory processes, and business rivalries without which the two competing drugs--Imbruvica and Calquence--would not have become publicly available.... An interesting tale of how personal ambition, scientific curiosity, and the pursuit of wealth led to life-extending drugs., A harrowing and improbable story of two rival blockbuster cancer drugs that takes us deep inside the coiling miasma of high-stakes modern medicine, where obsessive scientists, doctors, investors, middlemen, billionaires, and giant corporations alternate, collaborate, and clash to accomplish what none of them could possibly do on their own. Meticulously researched, vividly told, Nathan Vardi's tale presents a detailed and compelling portrait., A crash course in biotech success -- and failure.... For Blood and Money does an excellent job of highlighting the complexities and expense, both financial and personal, of drug development., A must-read for anyone who wants to understand how Wall Street investment leads to the products on pharmacy shelves. Nathan Vardi brings a deep knowledge and economical storytelling to the clash between two billionaires behind two cancer drugs and shows real humanity in describing the scientists who were often caught in the middle., For Blood and Money is a fascinating--and often disturbing--insider view of the genesis of a blockbuster drug, and the often-explosive clash of science, Wall Street cash, ego, and testosterone that are involved., [For Blood and Money ] is much more than a tale of the birth of a potent new cancer drug, as it reveals the split personality of biotech: an altruistic enterprise that creates breakthrough treatments for patients in need, and a bare-knuckle business that seeks to generate astronomic profits and crush competitors., For Blood and Money is a blast. Nathan Vardi shows the roles that greed, fear, determination, and, above all, ambition play in developing billion-dollar drugs. A ton of fun and full of insight., Nathan Vardi has crafted an intimate and gripping account of the rollercoaster journey a new drug takes from molecule to potential medicine. For Blood and Money is a page-turner, chock full of character and intrigue. With classic journalistic shoe leather, Vardi delivers the inside story of biotech, bringing readers into the bare-knuckle backroom of biopharma start-ups where the stakes couldn't be higher--especially for patients.--Charles Graeber, New York Times best-selling author of The Good Nurse and The Breakthrough Nathan Vardi tells an exciting story of the relentless focus and extraordinary effort required to bring a breakthrough to patients, providing rich detail on the delicate interplay between researchers, biopharma, investors, and regulators that leads to medical innovation.--Albert Bourla, CEO of Pfizer A harrowing and improbable story of two rival blockbuster cancer drugs that takes us deep inside the coiling miasma of high-stakes modern medicine, where obsessive scientists, doctors, investors, middlemen, billionaires, and giant corporations alternate, collaborate, and clash to accomplish what none of them could possibly do on their own. Meticulously researched, vividly told, Nathan Vardi's tale presents a detailed and compelling portrait of the ferocious but indispensable world that is 21st century pharmaceutical research, development, and marketing.--Barry Werth, author of The Billion Dollar Molecule and The Antidote For Blood and Money is a blast. Nathan Vardi shows the roles that greed, fear, determination, and, above all, ambition play in developing billion-dollar drugs. A ton of fun and full of insight.--Gregory Zuckerman, author of A Shot to Save the World A must-read for anyone who wants to understand how Wall Street investment leads to the products on pharmacy shelves. Nathan Vardi brings a deep knowledge and economical storytelling to the clash between two billionaires behind two cancer drugs and shows real humanity in describing the scientists who were often caught in the middle.--Matthew Herper, Senior Writer, STAT, Nathan Vardi tells an exciting story of the relentless focus and extraordinary effort required to bring a breakthrough to patients, providing rich detail on the delicate interplay between researchers, biopharma, investors, and regulators that leads to medical innovation., [For Blood and Money] is a fascinating look at the quest to develop a new drug for blood cancer that targets only cancerous cells and not the healthy kind., Nathan Vardi has crafted an intimate and gripping account of the rollercoaster journey a new drug takes from molecule to potential medicine. For Blood and Money is a page-turner, chock full of character and intrigue. With classic journalistic shoe leather, Vardi delivers the inside story of biotech, bringing readers into the bare-knuckle backroom of biopharma start-ups where the stakes couldn't be higher--especially for patients.
Synopsis
For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how the core team--denied their share of the profits--went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time. In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks--and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they're onto something big. What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi's narrative immerses readers in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction read, For Blood and Money illustrates why it's so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine., A sweeping business narrative and scientific thriller about what it takes to bring a wonder drug to market--and save thousands of lives., One of Scientific American's Best Staff Reads of 2023 A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market--and save countless lives. For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how members of the core team--denied their share of the profits--went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time. In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks--and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they're onto something big. What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi's narrative immerses readers in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction read, For Blood and Money illustrates why it's so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine., For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how the core medical team--denied their share of the profits--went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time. His narrative immerses readers in the recent explosion of biotech startups, where vivid characters navigate a world of corporate intrigue and ambiguous morality. For the scientists, doctors, and investors who risk everything to develop new, lifesaving treatments, the rewards can be measured in billions of dollars. For suffering patients, the stakes are life or death. Vardi's story illustrates why it's so hard to bring new drugs to market and how profit-driven venture capitalists are shaping the future of medicine., One of Scientific American's Best Staff Reads of 2023 A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market--and save countless lives.
Item description from the seller
Popular categories from this store
Seller feedback (18,143)
This item (1)
All items (18,143)
- eBay automated feedback- Feedback left by buyer.Past monthOrder completed successfully—tracked and on time
- eBay automated feedback- Feedback left by buyer.Past monthOrder completed successfully—tracked and on time
- eBay automated feedback- Feedback left by buyer.Past monthOrder completed successfully—tracked and on time
- w***m (191)- Feedback left by buyer.Past monthVerified purchaseThanks
Popular categories from this store
Seller feedback (18,143)
This item (1)
All items (18,143)
- eBay automated feedback- Feedback left by buyer.Past monthOrder completed successfully—tracked and on time
- eBay automated feedback- Feedback left by buyer.Past monthOrder completed successfully—tracked and on time
- eBay automated feedback- Feedback left by buyer.Past monthOrder completed successfully—tracked and on time
- w***m (191)- Feedback left by buyer.Past monthVerified purchaseThanks